Martin Tauschmann
Overview
Explore the profile of Martin Tauschmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karges B, Rosenbauer J, Stahl-Pehe A, Flury M, Biester T, Tauschmann M, et al.
Lancet Diabetes Endocrinol
. 2024 Dec;
13(2):88-96.
PMID: 39701114
Background: The effect of closed-loop insulin delivery on the risk of acute diabetes complications in people with type 1 diabetes is unclear. We investigated whether the rates of severe hypoglycaemia...
2.
Moser O, Zaharieva D, Adolfsson P, Battelino T, Bracken R, Buckingham B, et al.
Horm Res Paediatr
. 2024 Dec;
:1-28.
PMID: 39657609
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved...
3.
Moser O, Zaharieva D, Adolfsson P, Battelino T, Bracken R, Buckingham B, et al.
Diabetologia
. 2024 Dec;
68(2):255-280.
PMID: 39653802
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved...
4.
Ware J, Allen J, Boughton C, Wilinska M, Hartnell S, Thankamony A, et al.
Diabetes Care
. 2024 Oct;
47(12):2189-2195.
PMID: 39418532
Objective: We aimed to evaluate the longer-term safety and efficacy of hybrid closed-loop (CL) therapy in very young children with type 1 diabetes (T1D). Research Design And Methods: Following a...
5.
Wiegand S, Becker M, Schmid S, Weghuber D, Weihrauch-Bluher S, Reinehr T, et al.
Diabetes Obes Metab
. 2024 Sep;
26(12):5630-5635.
PMID: 39295083
No abstract available.
6.
Kietaibl A, Schutz-Fuhrmann I, Bozkurt L, Fruhwald L, Rami-Merhar B, Frohlich-Reiterer E, et al.
Wien Klin Wochenschr
. 2024 Aug;
136(Suppl 9):467-477.
PMID: 39196351
People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic...
7.
Fox D, Ware J, Boughton C, Allen J, Wilinska M, Tauschmann M, et al.
J Diabetes Sci Technol
. 2024 Mar;
:19322968241231950.
PMID: 38494876
Background/objective: The main objective of this study is to evaluate the incremental cost-effectiveness (ICER) of the Cambridge hybrid closed-loop automated insulin delivery (AID) algorithm versus usual care for children and...
8.
Cardona-Hernandez R, Dovc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, et al.
Pharmacol Res
. 2024 Feb;
202:107109.
PMID: 38413347
No abstract available.
9.
Cardona-Hernandez R, Dovc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, et al.
Pharmacol Res
. 2023 Aug;
195:106882.
PMID: 37543096
Type 1 diabetes (T1D) is the most frequent form of diabetes in pediatric age, affecting more than 1.5 million people younger than age 20 years worldwide. Early and intensive control...
10.
Alwan H, Ware J, Boughton C, Wilinska M, Allen J, Lakshman R, et al.
Diabetes Technol Ther
. 2023 May;
25(7):485-491.
PMID: 37229591
We aimed to assess whether percentage of time spent in hypoglycemia during closed-loop insulin delivery differs by age group and time of day. We retrospectively analyzed data from hybrid closed-loop...